‘ZyCov-D’ vaccine

  • IASbaba
  • August 21, 2021
  • 0
UPSC Articles
Print Friendly, PDF & Email

‘ZyCov-D’ vaccine

Part of: GS Prelims 

In news: The Drug Controller General has granted emergency approval to the Zycov-D, a COVID-19 vaccine.

  • This is the fifth vaccine, after Covishield, Covaxin, Sputnik V and Moderna to be approved for use in India. 

About Zycov-D

  • Zycov-D is a COVID-19 vaccine developed by the Ahmedabad based Zydus Cadilla group and is the first vaccine in India that can be administered to adults as well as those 12 and above. 
  • It’s also the only DNA-based vaccine in the world and can be administered without a needle, purportedly minimizing chances of reactions.
  • The vaccine has been developed in partnership with the Department of Biotechnology under the ‘Mission COVID Suraksha’.
  • The three-dose vaccine once administered produces the spike protein of the SARS-CoV-2 virus and elicits an immune response. 
  • The plug-and-play technology on which the plasmid DNA platform is based can be easily adapted to deal with mutations in the virus, such as those already occurring.

News Source: PIB

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel – https://t.me/IASbabaOfficialAccount

Subscribe to our YouTube Channel HERE to watch Explainer Videos, Strategy Sessions, Toppers Talks & many more…

Search now.....

Sign Up To Receive Regular Updates